Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has received an average rating of “Hold” from the fifteen research firms that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $30.69.
A number of research firms recently commented on ACHC. Guggenheim boosted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. TD Cowen raised their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Barclays lifted their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Finally, KeyCorp upped their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th.
View Our Latest Report on ACHC
Institutional Investors Weigh In On Acadia Healthcare
Acadia Healthcare Price Performance
NASDAQ:ACHC opened at $30.08 on Thursday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The business’s 50-day moving average price is $28.93 and its 200 day moving average price is $27.75. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $35.83. The firm has a market cap of $2.80 billion, a P/E ratio of -2.42, a PEG ratio of 9.42 and a beta of 0.63.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same period in the prior year, the company earned $0.83 EPS. Acadia Healthcare’s revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, sell-side analysts predict that Acadia Healthcare will post 1.55 earnings per share for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.
Acadia’s services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
- China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
- 3 REITs That May Win in a Higher Interest Rate Environment
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
